Okami Medical Receives Expanded Indication for the LOBO Vascular Occluder

ALISO VIEJO, Calif., Oct. 7, 2026 /PRNewswire/ — Okami Medical, a medical technology company developing novel vascular embolization solutions, announced today that the U.S. FDA has granted an expanded indication for its LOBO® Vascular Occlusion System. The expanded indication extends the…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks